EZZ Life Science (ASX: EZZ) appoints industry expert to lead next stage of growth (w/ Glenn Cross)

EZZ Life Science (ASX: EZZ) chairperson and non-executive director Glenn Cross joins Small Caps to discuss his role and plans in growing the company’s presence in the genomics space. EZZ Life Science has established collaborations with world-class research institutions and is committed to expanding its research and development in genomics. The company is focused on four key human health challenges – genetic longevity, human papillomavirus, helicobacter pylori and weight management.Articles:https://smallcaps.com.au/ezz-life-science-new-chairman-amid-launch-helicobacter-pylori-treatments/https://smallcaps.com.au/ezz-life-sciences-moves-into-genomics-precision-nutrition-space/https://smallcaps.com.au/ezz-life-science-transforms-distributor-integrated-producer-genomic-health-products/More company information:https://smallcaps.com.au/stocks/EZZ/See omnystudio.com/listener for privacy information.